Lanxess (LXS) – Investment Analysts’ Recent Ratings Updates

Lanxess (ETR: LXS) has recently received a number of price target changes and ratings updates:

  • 3/22/2018 – Lanxess was given a new €65.00 ($80.25) price target on by analysts at Barclays. They now have a “neutral” rating on the stock.
  • 3/20/2018 – Lanxess had its “buy” rating reaffirmed by analysts at DZ Bank AG.
  • 3/20/2018 – Lanxess was given a new €80.00 ($98.77) price target on by analysts at Citigroup. They now have a “buy” rating on the stock.
  • 3/20/2018 – Lanxess was given a new €72.00 ($88.89) price target on by analysts at Cfra. They now have a “buy” rating on the stock.
  • 3/19/2018 – Lanxess was given a new €67.00 ($82.72) price target on by analysts at Societe Generale. They now have a “neutral” rating on the stock.
  • 3/16/2018 – Lanxess was given a new €68.00 ($83.95) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 3/16/2018 – Lanxess was given a new €70.00 ($86.42) price target on by analysts at Credit Suisse Group AG. They now have a “neutral” rating on the stock.
  • 3/16/2018 – Lanxess was given a new €68.00 ($83.95) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 3/15/2018 – Lanxess was given a new €70.00 ($86.42) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 3/15/2018 – Lanxess was given a new €67.00 ($82.72) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 3/15/2018 – Lanxess was given a new €67.00 ($82.72) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 3/15/2018 – Lanxess was given a new €83.00 ($102.47) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 3/15/2018 – Lanxess was given a new €75.00 ($92.59) price target on by analysts at UBS. They now have a “buy” rating on the stock.
  • 3/15/2018 – Lanxess was given a new €83.00 ($102.47) price target on by analysts at equinet AG. They now have a “buy” rating on the stock.
  • 2/13/2018 – Lanxess was given a new €83.00 ($102.47) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 2/8/2018 – Lanxess was given a new €66.00 ($81.48) price target on by analysts at Barclays. They now have a “neutral” rating on the stock.
  • 2/6/2018 – Lanxess was given a new €75.00 ($92.59) price target on by analysts at Baader Bank. They now have a “neutral” rating on the stock.
  • 2/5/2018 – Lanxess was given a new €75.00 ($92.59) price target on by analysts at UBS. They now have a “buy” rating on the stock.
  • 1/25/2018 – Lanxess was given a new €72.70 ($89.75) price target on by analysts at Credit Suisse Group AG. They now have a “neutral” rating on the stock.

Shares of Lanxess AG (LXS) opened at €62.34 ($76.96) on Monday. Lanxess AG has a 1 year low of €59.89 ($73.94) and a 1 year high of €74.50 ($91.98). The stock has a market cap of $5,810.00 and a P/E ratio of 65.62.

LANXESS Aktiengesellschaft develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in four segments: Advanced Intermediates, Performance Chemicals, High Performance Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemicals and coatings industries; fine chemicals as precursors and intermediates for pharmaceuticals, agrochemicals, and specialty chemicals industries; customer-specific specialties; and tire chemicals.

Receive News & Ratings for Lanxess AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

FS Bancorp  Receives Daily Coverage Optimism Rating of 0.23
FS Bancorp Receives Daily Coverage Optimism Rating of 0.23
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Ooma  Share Price
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Ooma Share Price
VBI Vaccines  Receiving Somewhat Favorable News Coverage, Report Finds
VBI Vaccines Receiving Somewhat Favorable News Coverage, Report Finds
Continental Resources  Hits New 1-Year High and Low After Analyst Upgrade
Continental Resources Hits New 1-Year High and Low After Analyst Upgrade
Contrasting Valhi  and NL Industries
Contrasting Valhi and NL Industries
Stellite  Reaches Market Capitalization of $0.00
Stellite Reaches Market Capitalization of $0.00


© 2006-2018 Ticker Report. Google+.